Papers
12
Total Citations
138
H-Index
6
About
Xuepei Zhang is a pioneering urologic surgeon whose research centers on advancing robotic surgery for complex oncologic procedures, particularly those involving renal cell carcinoma with inferior vena cava (IVC) tumor thrombus. Dr. Zhang has made landmark contributions to the field by developing and validating novel robotic platforms and surgical techniques. Their most cited work (54 citations) established a decision-making scheme for robot-assisted cavectomy versus thrombectomy in Level II IVC thrombus, while a subsequent study (6 citations) detailed the first robot-assisted single-docking approach for Level III IVC tumor thrombectomy. Dr. Zhang has been instrumental in evaluating emerging robotic systems, including the Toumai® (21 citations) and MP1000 systems (14 citations), demonstrating their feasibility and noninferiority compared to the da Vinci platform in partial nephrectomy. Their research also addresses critical preoperative risk stratification, identifying predictors of early death in bladder cancer patients undergoing robot-assisted radical cystectomy (14 citations) and positive surgical margins in robot-assisted radical prostatectomy (8 citations). With over 135 total citations, Dr. Zhang’s work is expanding access to affordable robotic surgery while pushing the boundaries of what is technically achievable in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10